Reports for LORAZEPAM

Ingredient

LORAZEPAM

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LORAZEPAM INJECTION USP 4MG SOLUTION Resolved 2020-11-06 2022-01-25 127901
ATIVAN 2MG TABLET Resolved 2021-11-30 2022-02-01 150219
APO-LORAZEPAM 2MG TABLET Resolved 2022-04-01 2022-05-13 157698
ATIVAN 2MG TABLET Resolved 2022-09-26 2022-10-04 170189
PMS-LORAZEPAM 0.5MG TABLET Resolved 2023-02-08 2023-03-21 183870
LORAZEPAM SUBLINGUAL 0.5MG TABLET Resolved 2023-02-03 2023-04-17 183599
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2022-06-30 2023-04-28 163918
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2022-12-08 2023-04-28 177523
TEVA-LORAZEPAM 1MG TABLET Resolved 2022-06-30 2023-04-28 163912
LORAZEPAM SUBLINGUAL 1MG TABLET Resolved 2023-02-28 2023-05-01 185682

Showing 61 to 70 of 80

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LORAZEPAM 1MG TABLET Discontinued 2017-06-06 2017-06-07 11980
LORAZEPAM 2MG TABLET Discontinued 2017-06-06 2017-06-07 11983
LORAZEPAM 2MG TABLET Discontinued 2017-06-06 2017-06-07 11986
LORAZEPAM 0.5MG TABLET Reversed 2017-03-14 2017-07-31 2430
APO-LORAZEPAM 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
APO-LORAZEPAM 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
LORAZEPAM Discontinued 2020-02-27 2020-02-27 107347
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
PMS-LORAZEPAM 0.5MG TABLET Discontinued 2020-06-15 2021-10-27 117717
PMS-LORAZEPAM 1MG TABLET Discontinued 2020-06-15 2021-10-27 117720

Showing 1 to 10 of 13